Tokyo, April 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058951) titled 'Measurement of visually induced motion sickness in operations using a VR-HMD' on April 1.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Saitama Medical University
Condition:
Condition - Motion sickness
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Investigation on how to quantitatively measure the degree of visually induced motion sickness
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Viewing VR motion pictures
Eligibility:
Age-lower limit - 18
years-old
Gender - Male and Female
Key inclusion criteria - Subjects with decision-making capacity
Key exclusion criteria - Subjects under 40 years old for excluding the effect of disequilibrium of aging.
Target Size - 25
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 12 Month 01 Day
Anticipated trial start date - 2025 Year 12 Month 05 Day
Last follow-up date - 2027 Year 12 Month 20 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067416
Disclaimer: Curated by HT Syndication.
